Home
About
Warning Letter Wednesday
Work With Me
Testimonials
Appearances
Press
Regulatory Blog
Resources
More
Asa Waldstein
Community, Compliance, Natural Health
Marketing Strategy Compliance √
Comparison to drugs is high risk
5/31/23
“Arthritis” claims elevate risk
5/10/23
All claims should be substantiated
4/19/23
Claims in hashtags, videos, and testimonials should be avoided
3/29/23
Webinars are “fair game” for enforcement
3/8/23
Hire experts to help with 483 responses
2/15/23
Nutrient content claims must be compliant
1/25/23
Expect arterial health claims to be cited in the future
1/4/23
Product names are marketing
5/24/23
Ensure ingredients are lawful for supplements
5/3/23
All dietary ingredients must be tested for identity
4/12/23
Printed catalogs must be compliant
3/22/23
Scan marketing for “mid-risk” heart health claims
3/1/23
Key GMP learning opportunities explored
2/8/23
FDA will test suspicious products for drugs
1/18/23
Study citations are marketing
12/28/22
Ensure weight loss products are tested for drugs
5/17/23
Re-review marketing if FDA has inspected you
4/26/23
Use qualified reference samples
4/5/23
Remove testimonials with claims
3/15/23
Old social posts are “active” marketing
2/22/23
Learning from other’s mistakes is a good strategy
2/1/23
Remove COVID claims including on YouTube
1/11/23
Discussing ingredient benefits is marketing
12/21/22